Align Technology, Inc. (ALGN)

NASDAQ · Health Care · Medical Instruments & Supplies
By Alex · Tickerpine
$174.01
+1.06 (+0.61%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$12.36B
P/E (TTM)
30.1
Forward P/E
13.9
EPS (TTM)
$5.79
ROE
10.15%
Profit Margin
9.99%
Revenue Growth
4.30%
Dividend Yield
Beta
1.65
52W High
$200.44
52W Low
$122.00
Analyst Target
$208.60

ALGN stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$208.60
Implied upside
+19.9%

Wall Street analysts covering Align Technology, Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $208.60 — +19.9% versus the last price of $174.01. Targets reflect analyst opinion, not a guarantee.

What would an investment in ALGN be worth today?
Run ALGN through our free historical return calculator.
Calculate ALGN returns →

ALGN historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +22.6% +22.6% $1,226
3 years -53.0% -22.2% $470
5 years -75.5% -24.5% $245
10 years +87.3% +6.5% $1,873
20 years +2,684% +18.1% $27,842
Since 2001 +1,189% +10.5% $12,890

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in ALGN.

ALGN annual returns by year

2026 YTD +11.4%
2025 -25.1%
2024 -23.9%
2023 +29.9%
2022 -67.9%
2021 +23.0%
2020 +91.5%
2019 +33.2%
2018 -5.7%
2017 +131.1%

Congress trading in ALGN

7 members of Congress have disclosed trading ALGN — 8 purchases and 8 sales worth an estimated $159,501. Most recent disclosure: Sep 11, 2025.

See who in Congress traded ALGN →

About Align Technology, Inc.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Company website ↗

ALGN Key Statistics

Previous Close$172.96P/E Ratio30.1
Market Cap$12.36BPEG Ratio0.83
Revenue (TTM)$4.14BROE10.15%
Gross Margin70.36%ROA7.40%
Debt / Equity2.9Employees20,435

ALGN in plain English

ALGN stock: frequently asked questions

What is Align Technology, Inc.'s stock price today?

Align Technology, Inc. (ALGN) last traded at $174.01 on the NASDAQ. Over the past 52 weeks the stock has traded between $122.00 and $200.44.

Is ALGN stock a buy or a sell?

Wall Street analysts' consensus rating on ALGN is "Buy", with an average 12-month price target of $208.60 — about +19.9% versus the current price of $174.01. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in ALGN 10 years ago be worth today?

A $1,000 investment in Align Technology, Inc. made 10 years ago would be worth about $1,873 today (dividends reinvested) — a total return of 87%, or 6.5% per year.

Does ALGN pay a dividend?

No — Align Technology, Inc. does not currently pay a meaningful dividend. Returns for shareholders come from changes in the share price.

What is ALGN's P/E ratio?

ALGN trades at a trailing price-to-earnings ratio of 30.1, and 13.9 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade ALGN stock?

Yes — 7 members of Congress have disclosed trades in ALGN under the STOCK Act, totaling 8 purchases and 8 sales worth an estimated $159,501.

What is Align Technology, Inc.'s ticker symbol?

Align Technology, Inc. trades under the ticker symbol ALGN on the NASDAQ.

Compare ALGN with peers

ALGN vs LLYEli Lilly and Company $1,220.28 ALGN vs JNJJohnson & Johnson $260.86 ALGN vs ABBVAbbVie Inc. $248.76 ALGN vs UNHUnitedHealth Group Incorporated $405.59 ALGN vs MRKMerck & Company, Inc. $132.92

Data last refreshed from public sources. Figures may be delayed. Not investment advice.